AzurRx BioPharma's Unattributed Round

AzurRx BioPharma raised a round of funding on April 02, 2014.

AzurRx BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies for the treatment of gastrointestinal diseases and related conditions. MS1819 recombinant lipase for …

Articles about AzurRx BioPharma's Unattributed Round: